SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Portfolio Acquisition

7 Aug 2013 12:41

RNS Number : 1092L
Caledonia Investments PLC
07 August 2013
 



 

 

Caledonia Investments plc

 

 

 

CALEDONIA INVESTMENTS PLC ACQUIRES THE CARE HOMES OPERATOR, CHOICE CARE GROUP

 

Caledonia Investments plc ("Caledonia") is pleased to announce that it has acquired Choice Holdings Ltd, Truecare Holdings Ltd and Choice Pathways Ltd (together "Choice Care Group" or "Choice" or the "Group") from Sovereign Capital in a transaction which values the business at £86 million. Choice Care Group provides support services for adults with learning disabilities, mental health disorders or complex needs through a portfolio of 47 residential care homes, owned and operated in the South of England.

 

Caledonia has subscribed £49.5 million in cash at completion for an initial 97.7% stake, the balance of the equity being rolled over by the management team led by Chief Executive, Edwina Johnston. The Royal Bank of Scotland plc, AIB Group (UK) plc and Santander UK plc (together "the Banks") have provided £40 million of senior debt financing. Both Caledonia and the Banks have committed to provide additional capital to fund the future development of Choice supporting management's growth plans for the Group.

 

Edwina Johnston has led Choice since 2009 as CEO and was previously the Group's CFO from 2002. She has overseen the development of Choice into the leading care business it is today. Choice places the delivery of care at the heart of its business model seeking to deliver positive care outcomes for its service users at all times. Choice enjoys 100% CQC compliance.

 

For the financial year to 30 September 2012, Choice Care Group generated EBITDA of £8.9 million, made combined profit before tax of £3.2 million and had gross assets of £45.8 million. From the outset, Choice will pay a running yield to Caledonia that is forecast to build over the life of the investment.

 

Commenting on the acquisition, Duncan Johnson, Caledonia's Head of Unquoted Investments, said:

 

"We are delighted to back Edwina Johnston and her management team in the buy-out of Choice. The group is recognised as a premium asset in the learning disability sector providing exceptional levels of care for its service users. Choice's estate is well invested and represents a solid platform for growth.

 

We look forward to a rewarding relationship with Edwina, Choice and its service users in the years ahead."

 

Edwina Johnston commented:

 

"It is great to have the backing of Caledonia and their long term support for our continuing investment plans. Under their ownership we can continue our expansion plans, adding new homes across the South, as well as maintain our continuous improvement plans across our portfolio ensuring we maintain our reputation for the very highest standards of care for our service users."

 

 

Will Wyatt, CEO of Caledonia commented:

 

"Our investment in Choice represents another positive step in the development of Caledonia's unquoted investment business, building upon our reputation as a measured, long-term investor in the unquoted arena. Choice fits well with the investment criteria we have set out to shareholders and I am confident it will deliver positive returns from the continuing growth of the business."

 

7 August 2013

For further information contact:

 

 

Caledonia Investments plc

 

Will Wyatt,

Chief Executive

+44 20 7802 8080

Duncan Johnson,

Head of Unquoted Investments

 

 

 

Media contact:

 

 

 

Tulchan Communications

 

Peter Hewer

+44 20 7353 4200

Katerina Soumilova

 

 

END

 

 

Notes for editors:

 

Caledonia Investments plc

 

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of approximately £1.3bn. The company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing dividend for 45 years.

 

In the unquoted arena, Caledonia seeks to invest £20 to £50 million in private companies either on a majority or minority basis in situations where it believes there to be a good opportunity for building value over the longer term.

 

For additional information on Caledonia, please visit www.caledonia.com. Neither the contents of the company's website nor the contents of any website accessible from hyperlinks on the company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

 

Choice Care Group

 

Choice is headquartered in Reading, Berkshire and operates in the surrounding regions. The business owns and operates 47 residential care homes for people with Learning Disabilities or mental health disorders. In addition, through its subsidiary, Excel Support Services, the Group provides supported living services for additional service users in the same areas.

 

Choice employs in excess of 1,200 employees throughout the business.

 

Choice's strategy is to develop additional homes in its current areas of geographical focus as well as entering adjoining counties via new home development. Choice's business model and measured growth plans result in the delivery of care being placed at the heart of the business.

 

For additional information on Choice, please visit www.choicecaregroup.com. Neither the contents of the company's website nor the contents of any website accessible from hyperlinks on the company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

 

Transaction

 

The transaction was led by Charlie Edwards, Duncan Johnson and Sally Flanagan on behalf of Caledonia. Caledonia was advised by Osborne Clark (Mark Spinner and Ben Truman), DC Advisory (Richard Clark and Phillip Gutzwiller), Connell Consulting (Clare Connell), Deloittes (Tim Haden) and Catalysis (Mike Hicks). Insurance advice was provided by both JLT and Aon. PricewaterhouseCoopers (Jason Wakelam) provided financial due diligence advice.

 

Banking facilities to support the transaction have been provided by RBS, AIB and Santander. The transaction was led on behalf of the banks by Mark Ward (RBS) with advice from Hogan Lovells (Stuart Brinkworth).

 

The Management team was advised by Chris Spanoudakis from Equita Corporate Finance as well as by CMS Cameron McKenna.

 

Sovereign Capital was advised by Jefferies International and CMS Cameron McKenna.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUGUBWRUPWGGM
Date   Source Headline
11th Jun 20263:30 pmRNSAnnual report 2026 and notice of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20261:39 pmRNSDirector/PDMR Shareholding
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20269:00 amRNSNet Asset Value(s)
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20265:08 pmRNSDirector/PDMR Shareholding
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202611:02 amRNSCompletion of Stonehage Fleming sale
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20269:42 amRNSDirector/PDMR Shareholding
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:34 pmRNSDirector Declaration
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSBoard changes
19th May 20267:00 amRNSFinal Results
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSNotice of Results
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:32 pmRNSHolding(s) in Company
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 202611:00 amRNSNet Asset Value(s)
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20264:39 pmRNSDirector Declaration
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:47 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20263:51 pmRNS-RQuotedData's In The HotSeat Special
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.